Europe · Wires & real time · Reuters US Markets

Swiss drug developer Windward Bio files for US IPO

Published by Reuters US Markets · United Kingdom 11 h ago

Windward Bio filed for a US initial public offering on Friday, becoming the latest drug developer seeking to capitalize on renewed ‌investor interest in biotech listings.

Read the full article on Reuters US Markets Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

TASS

Senators plan to block Trump’s nominees over Ukraine satellite network restrictions — NYT

Anadolu Agency

New York stock market closes week lower

Reuters

First Russian diesel from Putin-Trump deal heading for US, data shows

Reuters Technology

AI 'hallucinations' in court filings show signs of slowdown, but judges still sound alarms

Fastmarkets

Fastmarkets proposes calculated FOB South America lithium carbonate, hydroxide prices

Reuters Business